Zogenix - Top 20 VC deals of 2007
Company: Zogenix
Based: San Diego, CA
Amount: $78.8M
Investors: Abingworth Management, Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Undisclosed Investor
Scoop: Zogenix is developing CNS disorders and pain treatments. In December 2007 the company submitted an NDA for sumatriptan DosePro, a needle-free, disposable, subcutaneous delivery system for migraine. Zogenix is also working on a Phase III controlled release opioid product it in-licensed from Elan.
More News:
Zogenix gains $60M in new VC funds. Report
Zogenix raises $18M in preferred stock financing. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
